EKO International (EKNL), NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.
Belize City, Belize -- (SBWIRE) -- 10/05/2012 -- EKNL unleashed a MONSTER update which just put them on a different playing field and definitely worth repeating again.
EKO, NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.
Unbelievable and when the market starts to get wind that EKNL is already providing 100 Walmart-Canada stores with Neurometrix NC-stat® | DPN Check™ testing units, prices will go insane. Investors actually got a taste of it yesterday with EKNL closing at $0.18 up 38.46% on over 1 million shares traded.
This Monster update has prompted xtremepicks to revisit their research report with initial target of $1.00 per share this weekend. Walmart is a HUGE addition to EKNL’s business plan that cannot be ignored.
View the research report at - http://www.xtremepicks.com/reports/eknl
The Pieces are falling into place quickly:
EKNL now has a monster super chain like Walmart as a patient referral partner for it FREMS technology.
EKNL is already teaming up with HUGE medical companies like Neurometrix, and the resource and backing of world renowned talents like Dr. Ziemer and Dr. Snow.
EKNL already announced the first of many clinics, the Mayer Institute to start treating patents with their FDA approved FREMS technology.
This is just insane, but whats even more interesting is the similarities between EKNL and xtremepicks 2011 monster FUSE Science (DROP) which jumped from pennies to hit $1.25.
DROP was xtremepicks trophy winner with 83,000% gains, and they guarantee EKNL will be their trophy winner for 2012.
If investors look at the initial stages of DROP and what is emerging with EKNL, it’s excitingly a very similar pattern as seen below.
Actually, both set up major breakout patterns at similar key levels. What xtremepicks have seen in DROP they are now seeing in EKNL and the start of a MAJOR breakout phase. DROP has it’s Tiger Woods, but EKNL just announced Wal-Mart - expect a series of other MAJOR updates that will pale in comparison!
http://www.xtremepicks.com/wp-content/uploads/2012/10/EKNLDROP.gif
What also makes EKNL a greater opportunity than DROP is that float is much smaller than DROP and insiders already expressed views that they are not selling with goals to push EKNL to dollar levels and then uplist to the big boards.
Similar to xtremepicks other recent Medical Company monster LFVN which not only jumped from pennies to over $3, it uplisted into the Nasdaq board - a definite possibility and goal for EKNL.
Research report to be revisited this weekend
DPN Device Screen with test results
NOW with Wal-Mart on board and many additional updates to be unleashed from EKNL that will be truly “mind blowing”, xtremepicks will not only be featuring EKNL for another month, but they have decided to revisit our Research report which had initial targets of $1 per share, THIS WEEKEND.
Investors definitely want to hold on tight for next week’s fireworks!
EKO International Corp.
About EKO International
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
About Xtremepicks.com:
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep informed of the latest movers. Xtremepicks.com penny stock newsletter is the trading connection and remember to always do research, use stop loss orders to protect, and book profits when in a position to do so. Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do own due diligence. Xtremepicks did not receive any compensation for the distribution of this press release. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)